Rupesh Rajesh Kotecha, MD

Rupesh Rajesh Kotecha, MD

Rupesh Kotecha, M.D., is a radiation oncologist at Miami Cancer Institute. Dr. Kotecha has specialized training and experience in utilizing the latest in radiation therapy treatment techniques to treat cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has a specific interest and expertise in the use of stereotactic radiosurgery in the management of brain metastases to help improve both patient outcomes and quality of life.

View full profile

Related Videos

Novel Radiation Therapies for Gliomas: Tumor-Treating Fields and Proton Therapy Video

Novel Radiation Therapies for Gliomas: Tumor-Treating Fields and Proton Therapy

Yazmin Odia, MD, Rupesh Kotecha, MD, and Minesh Mehta, MD discuss the current role and patient selection of tumor-treating fields in the treatment of gliomas. They also look at the rationale for proton beam therapy in treatment.

Current Radiation Treatment Approaches for Brain Metastases Video

Current Radiation Treatment Approaches for Brain Metastases

Yazmin Odia, MD, Rupesh Kotecha, MD, and Minesh Mehta, MD discuss the use of stereotactic radiosurgery and whole-brain radiotherapy in the treatment of brain metastases.

Current Drug Treatment Approaches for Brain Metastases Video

Current Drug Treatment Approaches for Brain Metastases

Yazmin Odia, MD, Rupesh Kotecha, MD, and Minesh Mehta, MD discuss the targeted therapies that have shown particular efficacy in brain metastases.

Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment Survival Video

Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment Survival

When Gwen Watson was diagnosed with glioblastoma (GBM), an aggressive brain cancer, she and her husband didn’t hesitate to drive four and a half hours from their home in DeLand, Florida, to Baptist Health’s Miami Cancer Institute so that ...